BioScience Health Innovations, Inc.
BHIC
$1.00
-$8.01-88.90%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.17M | 2.79M | 1.85M | 1.54M | 1.16M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.17M | 2.79M | 1.85M | 1.54M | 1.16M |
| Cost of Revenue | 1.43M | 824.10K | 536.00K | 331.90K | 215.50K |
| Gross Profit | 2.73M | 1.97M | 1.31M | 1.21M | 942.00K |
| SG&A Expenses | 1.78M | 1.40M | 1.22M | 1.17M | 1.02M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.22M | 2.23M | 1.76M | 1.50M | 1.23M |
| Operating Income | 950.70K | 567.20K | 87.00K | 38.60K | -74.70K |
| Income Before Tax | 950.70K | 567.20K | 87.00K | 38.60K | -74.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 0.95 | 0.57 | 0.09 | 0.04 | -0.07 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 950.70K | 567.20K | 87.00K | 38.60K | -74.70K |
| EBIT | 950.70K | 567.20K | 87.00K | 38.60K | -74.70K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 172.58M | 170.26M | 167.73M | 165.86M | 164.13M |
| Average Diluted Shares Outstanding | 175.10M | 172.78M | 169.83M | 166.28M | 164.55M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |